Main clinical studies of Bruton’s tyrosine kinase inhibitors (BTKis)
Type de matériel :
TexteLangue : français Détails de publication : 2024.
Ressources en ligne : Abrégé : Quality of life evaluation is crucial in therapeutic trials in hematology, but is not yet recognized as the only true patient-centered primary endpoint. For chronic lymphocytic leukemia patients, how can we move beyond focusing solely on progression-free survival to truly consider overall survival with good quality of life?
Nous n'avons pas d'exemplaire de ce document
86
Quality of life evaluation is crucial in therapeutic trials in hematology, but is not yet recognized as the only true patient-centered primary endpoint. For chronic lymphocytic leukemia patients, how can we move beyond focusing solely on progression-free survival to truly consider overall survival with good quality of life?
Réseaux sociaux